Professor Amjad Khan
DPhil (Oxford), M.Sc (Oxford)
- Experimental Medicine and Immunotherapeutics Pharmacology
- Randomized Clinical trials
I studied DPhil at Oxford under the supervision of Prof. Chris Schofield (INEOS Oxford Institute for AMR Research) and Prof. Tim Claridge (NMR) working on developing methodologies for target structure-based drug design approach and understanding the underlying mechanism of enzymatic functions involved in human physiology and disease condition. Prior to my DPhil, I studied M.Sc at Oxford under the supervision of Prof. Michael Willis working on the synthesis of novel Dihydropyrimidinone (DHPM) agents.
My research is focused on two areas;
- Exploring pharmacologically active agents that contribute to improvement of human immune system against developing infection and diseases, both in acute and chronic conditions.
- Understanding the clinical biochemistry, physiology and mechanism of action of human enzymes targeted for therapeutic interventions.